A continuous intravenous insulin infusion protocol to manage high-dose methylprednisolone-induced hyperglycemia in patients with severe COVID-19.
Yoshihito TakahashiHiroshi MatsuuraHisaya DomiHitoshi YamamuraPublished in: Clinical diabetes and endocrinology (2022)
This insulin protocol gradually brought the blood glucose level within target levels in severe COVID-19 patients treated with high-dose steroid. Some hyperglycemia events were detected despite patients being under the protocol in the initial phase, and thus, minor modifications of the protocol might be required in the initial phase.
Keyphrases
- high dose
- blood glucose
- low dose
- randomized controlled trial
- coronavirus disease
- sars cov
- type diabetes
- stem cell transplantation
- glycemic control
- end stage renal disease
- diabetic rats
- ejection fraction
- early onset
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- oxidative stress
- respiratory syndrome coronavirus
- metabolic syndrome
- insulin resistance
- blood pressure
- endothelial cells
- patient reported outcomes
- patient reported